Page 16 - Kd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration gave the SGLT2 inhibitor empagliflozin (Jardiance) a new indication for treating adults with isolated chronic kidney disease. ....
IBM's stock rallied Wednesday after RBC Capital's Matthew Swanson set a Wall Street-high price target that suggests a nine-year high is on the horizon. ....
Adults aged 18-39 years had a significant prevalence of subclinical kidney dysfunction that linked with a higher CVD event rate in a retrospective analysis of 8.7 million Canadian adults. ....
KULAI - The Communications and Digital Ministry (KKD) expects to table the proposed amendments to the Communications and Multimedia Act 1998 in Parliament early next year.
Its. ....
Treatment with the aldosterone synthase inhibitor lorundrostat significantly decreased automated office systolic blood pressure in adults with uncontrolled hypertension in the phase 2 TARGET-HTN trial. ....